Gritstone bio Investor Relations Material
Latest events
Status Update
Gritstone bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Gritstone bio Inc
Access all reports
Gritstone bio Inc. is a biotechnology company that develops immunotherapies aimed at treating cancer and infectious diseases. The company leverages its expertise in genomics, machine learning, and immune system biology to create therapeutic vaccines and antibody-based treatments. Gritstone bio focuses on advancing precision medicine through innovative platforms designed to stimulate the immune system to recognize and combat specific disease targets. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
GRTS.Q
Country
🇺🇸 United States